Year-over-year, this metric grew by 211.3%, from -$213.00M to $237.00M. Over 4 years (FY 2021 to FY 2025), Operating Cash Flow shows relatively stable performance with a 1.0% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.
An increase indicates strong operational efficiency and cash generation, while a decrease may signal operational challenges or issues with working capital management.
This metric represents the total cash generated or consumed by a company's core business operations during a specific pe...
Standard across all industries; peers in the medical device and diagnostics sector typically maintain high conversion ratios of net income to operating cash flow.
net_cash_from_operating| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $580.00M | $1.28B | $1.11B | $1.55B | -$1.88B | $3.00B | $1.44B | $1.15B | $122.00M | $1.02B | $670.00M | $554.00M | $834.00M | $130.00M | $483.00M | -$213.00M | $886.00M | $1.70B | $0.00 | $237.00M |
| QoQ Change | — | +120.7% | -13.7% | +40.6% | -220.7% | +259.9% | -52.0% | -19.9% | -89.4% | +732.0% | -34.0% | -17.3% | +50.5% | -84.4% | +271.5% | -144.1% | +516.0% | +91.4% | -100.0% | — |
| YoY Change | — | — | — | — | -423.4% | +134.4% | +30.4% | -25.7% | +106.5% | -66.2% | -53.5% | -52.0% | +583.6% | -87.2% | -27.9% | -138.4% | +6.2% | >999% | -100.0% | +211.3% |